Clik here to view.
Study Evaluates Utility of Masimo SpHb® During High-Blood-Loss Oncosurgery
NEUCHATEL, Switzerland Masimo (NASDAQ:MASI) announced today the findings of a recently published study in which researchers in New Delhi, India evaluated the utility of Masimo SpHb®, noninvasive,...
View ArticleClik here to view.
KYOCERA Begins Research in AI-based Image Recognition to Help Diagnose Skin...
KYOTO, Japan Kyocera Corporation (NYSE:KYO)(TOKYO:6971) announced today that its subsidiary, Kyocera Communication Systems Co., Ltd. (hereafter “KCCS”), has started joint research with the...
View ArticleClik here to view.
研究评估Masimo SpHb®在高失血量肿瘤手术中的功用
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ:MASI)今天发布了印度新德里研究人员最新发表的一项研究结果，该研究评估Masimo无创连续血红蛋白测量指标SpHb®在预期高失血量的肿瘤手术患者中的功用1。...
View ArticleClik here to view.
失血量が多い腫瘍手術中における研究でMasimo SpHb®の有用性を評価
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、インドのニューデリーの研究者らが最近発表した研究の知見について発表しました。この研究は、大量の失血が予想される患者を対象に、非侵襲的かつ連続的なヘモグロビン測定値であるMasimo SpHb®の腫瘍手術中における有用性を評価したものです1。...
View ArticleClik here to view.
From Genetic Genealogy to Rapid DNA Analysis and MPS, Explore Real-Word...
MADISON, Wis. The 28th International Symposium on Human Identification (ISHI) will feature presentations from leading professionals in the fields of forensic DNA analysis, genetic genealogy,...
View ArticleClik here to view.
NantHealth and Asia Genomics Announce Global Expansion of GPS CancerTM in...
CULVER CITY, Calif. & SINGAPORE NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced that it has entered into an agreement for GPS...
View ArticleClik here to view.
CORRECTING and REPLACING KYOCERA Begins Research in AI-based Image...
KYOTO, Japan Fifth paragraph, first sentence of release dated August 29, 2017, should read: The project benefits from a database of more than 20,000 clinical images… (instead of The project benefits...
View ArticleClik here to view.
Leading Immunologists Gather in New Delhi to Confront Celiac Disease
CAMBRIDGE, Mass. & NEW DELHI The International Society for the Study of Celiac Disease (ISSCD), a non-profit organization of professionals working in the field of celiac disease and...
View ArticleClik here to view.
BioMarker Strategies Announces Two New Patents Granted in Japan, Covering the...
ROCKVILLE, Md. BioMarker Strategies, LLC, today announced that the Japan Patent Office has granted new patents covering the Company’s SnapPath® Cancer Diagnostics System technology and its PathMAP®...
View ArticleClik here to view.
Yamaha Motor Releases the Cell Picking & Imaging System CELL HANDLER(TM)
IWATA, Japan Yamaha Motor Co., Ltd. (TOKYO:7272) (ISIN:JP3942800008) announced today that it has developed the cell picking/imaging system CELL HANDLERTM. This device performs part of the testing...
View ArticleClik here to view.
1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC) today announced that it has recruited and treated its first patient in a randomised, controlled clinical trial of...
View ArticleClik here to view.
Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs
SANDY, Utah Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, and...
View ArticleClik here to view.
Shionogi Inc. and Purdue Pharma L.P. to Present Data from Naldemedine Studies...
OSAKA, Japan & FLORHAM PARK, N.J. & STAMFORD, Conn. Purdue Pharma L.P. and Shionogi Inc. will present results from four research studies of naldemedine during the 11th Annual PAINWeek®...
View ArticleClik here to view.
重篤な先天性心疾患の新生児スクリーニングにおける研究で、スマートデバイス併用型パルスオキシメーターMasimo iSpO2® Rxの性能を評価
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、マーストリヒトの研究者らが最近発表した研究の知見について発表しました。オランダの研究者らは、重篤な先天性心疾患（CCHD）の新生児スクリーニングにおけるMasimo iSpO2® Rxの性能を評価しました1。iSpO2 RxはMasimo Measure-through Motion and Low...
View ArticleClik here to view.
搭配Masimo iSpO2® Rx智能设备的脉搏氧饱和度仪在新生儿危重型先天性心脏病筛查中的功效研究
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了近期发表的一项研究成果，荷兰马斯特里赫特的研究人员在该研究中评估了Masimo iSpO2® Rx在新生儿危重型先天性心脏病(CCHD)筛查中的功效1。iSpO2 Rx是搭配智能设备的脉搏氧饱和度仪，搭载Masimo移动和低灌注下测量™脉搏氧饱和度技术。...
View ArticleClik here to view.
Endologix Announces Collaboration Agreements with Japan Lifeline for the...
IRVINE, Calif. Endologix, Inc. (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has signed a joint research and development agreement,...
View ArticleClik here to view.
Research Definitively Confirms Superiority of ReCell® for Treatment of Burn...
VALENCIA, Calif. & PERTH, Australia & LONDON The ReCell® Autologous Cell Harvesting Device effectively reduces the amount of skin harvesting required relative to conventional treatment of...
View ArticleClik here to view.
Kaneka Eurogentec Announces the Construction of a New Large Scale...
SERAING, Belgium Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), announced today that its board has approved the construction of a...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Limited to Present at the Morgan Stanley Annual...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that the Company will be present at the Morgan Stanley 15th Annual Global...
View ArticleClik here to view.
Aurigene, a Wholly Owned Subsidiary of Dr. Reddy’s, and Curis Announce CA-170...
BANGALORE, India Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and a specialized biotechnology company...
View Article